Trial intelligence / Profile preview

Potassium Sodium Hydrogen Citrate for Renal Stone Recurrence

NCT01329042Phase 4Completed

Sponsor
Ouiheng International Healthcare
Start
May 2005
Primary completion
Oct 2007
Modality
Small Molecules
01

Overview

A Phase 4 trial of potassium citrate + sodium citrate hydrate in calcium oxalate urolithiasis (CaOx), sponsored by Ouiheng International Healthcare. Started May 2005; status: completed.

02

Drugs

potassium citrate + sodium citrate hydrate
03

Conditions

calcium oxalate urolithiasis (CaOx)

Beyond the preview

Go deeper on NCT01329042.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01329042.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call